Tag Archives: Aripiprazole

Introducing the Journal of Geriatric Care and Research (JGCR)

Posted on July 3, 2016 by Dementia and Elderly Care News

Summary The Journal of Geriatric Care and Research (ISSN 2397-5628) is a recently launched, locally edited, multi-disciplinary peer-reviewed international journal, which covers topics of relevance to the care of the elderly. Concerning Guidelines on the Use of Antipsychotics for Agitation … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Guidelines, International, Local Interest, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Pharmacological Treatments, Quick Insights, Wales, Wolverhampton | Tagged Academia.edu, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Adverse Effects, Aggression, Aggressive Behaviour, Agitation, Agitation and Aggression, Alternatives to Antipsychotics, Alzheimer’s Disease-Related Agitation, American Journal of Psychiatry, American Psychiatric Association (APA), American Psychiatric Association: Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia (2016), Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Neuroleptic Sensitivity, APA Practice Guidelines, Aripiprazole, Atypical Antipsychotics, Avoidable Harm, Avoidable Hospital Mortality, Avoidable Mortality, Behavioural and Psychological Symptoms of Dementia (BPSD), Benefits and Risks of Antipsychotic Treatment, Betsi Cadwaladr University Health Board, Black Country, Black Country Partnership NHS Foundation Trust, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, British Indian Psychiatric Association (BIPA), Community and Mental Health Trusts, Dr Sarmishtha Bhattacharyya: Consultant in Old Age Psychiatry at Wrexham Maelor Hospital, Faculty of Health and Social Care: University of Chester, Geriatric Care and Research Organisation (GeriCaRe), Haloperidol, Improving Prescribing Practice, Inappropriate Prescribing, Inappropriate Use of Antipsychotics in Dementia, Journal of Geriatric Care and Research (JGCR), Learning Disabilities, Medication Reviews, Mental Health Trusts, North Wales, Olanzapine, Over-Medication, Over-Medication for People With Learning Disabilities, Over-Prescribing, Overprescribing, People With Learning Disabilities, Personalised Care Versus Guideline-Based Care, Personalised Medicine Versus Guideline-Based Medicine, Potential Harms of Antipsychotic Use, Potentially Inappropriate Prescribing, Prescribing Anti-Psychotic Drugs to People with Dementia, Prescribing of Antipsychotic Drugs For People With Dementia, Prescribing of Antipsychotic Drugs For People With Learning Disabilities, Psychosis in Patients With Dementia, Quetiapine, Reducing Agitation and Distress, Reducing Antipsychotic Prescriptions in Dementia, Reducing Avoidable Premature Mortality, Reducing Inappropriate Use of Antipsychotics, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Violence and Aggression, Risperidone, Safe and Compassionate Care, United States, University of Chester, USA, Violence and Aggression, West Midlands, Wrexham, Wrexham Maelor Hospital, Ziprasidone | Leave a comment

Antipsychotics for the Management of Agitation in Adults with Personality Disorders or Cognitive Impairment (CADTH)

Posted on October 3, 2013 by Dementia and Elderly Care News

Summary This Canadian Agency for Drugs and Technologies in Health (CADTH) report summarises existing guidelines and reviews on the clinical effectiveness of antipsychotics for reducing agitation in adults with personality disorders or cognitive impairment. Full Text Link Reference Antipsychotics for … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Researchers (mostly), International, Management of Condition, Pharmacological Treatments, Quick Insights, Standards, Systematic Reviews | Tagged Aggression, Aggressive Behaviour, Agitation, AGREE Collaboration, AMSTAR, Anger Irritability and Assault Questionnaire, Antipsychotics Side Effects, Appraisal of Guidelines for Research and Evaluation (AGREE), Aripiprazole, Atypical Antipsychotics, Barratt Impulsiveness Scale, Borderline Personality Disorder (BPD), BPD Severity Index, Buss-Durkee Hostility Inventory, Canadian Agency for Drugs and Technologies in Health (CADTH), Clozapine, Cognitive Impairment, First Generation Antipsychotics (FGA), Haloperidol, HSCL-Anger-Hostility, Mild Cognitive Impairment (MCI), Modified Overt Aggression Scale, National Collaborating Centre for Mental Health, Olanzapine, Overt Aggression Scale Modified, Psychological Symptoms of Dementia (BPSD), Quetiapine, Rapid Response Service (CADTH), Reducing Agitation and Distress, Reducing Inappropriate Use of Antipsychotics in Dementia, Second Generation Antipsychotics (SGA), State-Trait Anger Expression Inventory, Systematic Reviews and Meta-Analyses, Thiothixene, Ward Scale of Impulsive Action, World Federation of Societies of Biological Psychiatry (WFSBP), Zanarini Rating Scale for Borderline Personality Disorder, Ziprasidone | Leave a comment

Comparative Mortality Risks from Antipsychotics in Community-Dwelling Older Adults (British Journal of Psychiatry)

Posted on August 12, 2013 by Dementia and Elderly Care News

Summary A US observational study of 136,393 people, aged 65 years and older, and living in the community, who had recently started taking antipsychotics, was performed to estimate the comparative mortality risks of commonly prescribed antipsychotics. These individuals had recently … Continue reading →

Posted in Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Pharmacological Treatments, Practical Advice, Quick Insights | Tagged Antipsychotic Drugs, Antipsychotic Prescribing in Nursing Homes in the United States, Antipsychotics, Antipsychotics in Elderly People with Dementia, Antipsychotics-Related Mortality Risks, Aripiprazole, Atypical Antipsychotics, Avoidable Mortality, Boston, Brigham and Women's Hospital and Harvard Medical School, British Journal of Psychiatry, College of Physicians and Surgeons: Columbia University, Columbia University, Community-Dwelling Older Adults, Comparative Mortality Risks from Antipsychotics, Department of Medicine: Brigham and Women's Hospital and Harvard Medical School, Department of Pharmacy Practice and Administration: Rutgers University, Department of Psychiatry: Columbia University, Department of Psychiatry: Duke University Medical Center, Department of Psychiatry: Vanderbilt University School of Medicine, Differemtial Antipsychotic-Related Mortality Risks, Differential Risk of Death (Antipsychotic Drugs), Division of Pharmacoepidemiology and Pharmacoeconomics: Brigham and Women's Hospital and Harvard Medical School, Duke University Medical Center, Ernest Mario School of Pharmacy: Rutgers University, Haloperidol, Health Care Policy and Aging Research: Rutgers University, Institute for Health, Institute for Health: Rutgers University, Massachusetts, Mortality Rates, Mortality Statistics, New Brunswick, New Jersey, New York, New York State Psychiatric Institute, Olanzapine, Prescribing of Antipsychotic Drugs For People With Dementia, Preventable Mortality, Quetiapine, Reducing Antipsychotic Medication in Care Homes, Risperidone, Rutgers University, USA, Vanderbilt University School of Medicine, Ziprasidone | Leave a comment

Antipsychotics-Related Mortality Risk in Nursing Home Dementia Patients (BMJ / BBC News)

Posted on February 29, 2012 by Dementia and Elderly Care News

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 8, March 2012]. Summary Some antipsychotic medications increase the risk of death in patients with dementia more than others, according to a US study … Continue reading →

Posted in Acute Hospitals, Age UK, Antipsychotics, Community Care, Dementia Action Alliance, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged Antipsychotics-Related Mortality Risks, Aripiprazole, Atypical Antipsychotics, BBC Health News, Behavioral and Psychological Symptoms of Dementia (BPSD), BMJ, BPSD: Behavioral and Psychological Symptoms of Dementia, Differemtial Antipsychotic-Related Mortality Risks, Differential Risk of Death (Antipsychotic Drugs), Haloperidol, Harvard Medical School, Medicaid, Medicare, Minimum Data Set, National Death Index, Nursing Homes, Nursing Homes in the United States, Olanzapine, Psychological Symptoms of Dementia (BPSD), Quetiapine, Risperidone, Ziprasidone | Leave a comment

Tag Archives: Aripiprazole

Antipsychotics for the Management of Agitation in Adults with Personality Disorders or Cognitive Impairment (CADTH)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites